Miltenyi Biotec Clinimacs Cd19 Gmp Microbeads

Miltenyi Biotec As a B cell lineage marker, CD19 is expressed from the early pro-B cell stage to the B cell lymphoblast stage; however, CD19 is down-regulated as B cells mature to plasma cells. The CD19 antigen is also expressed on most malignant B cells and on a subset of follicular dendritic cells. | The CliniMACS® CD19 Product Line consists of murine anti-CD19 monoclonal antibodies conjugated to superparamagnetic iron dextran particles. | One vial contains 7.5 mL sterile, non-pyrogenic solution. | The performance of the CliniMACS CD19 Product Line depends on the individual separation strategy. For information on respective capacities, refer to the CliniMACS User Manual or contact your local representative. | Please inquire about required CliniMACS System components and accessories. - MLTY (Additional S&H or Hazmat Fees May Apply)